|
|
Volumn 435, Issue 7045, 2005, Pages 1008-1009
|
|
Racially targeted drug set for approval
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GEFITINIB;
HYDRALAZINE PLUS ISOSORBIDE DINITRATE;
EPIDERMAL GROWTH FACTOR RECEPTOR;
HYDRALAZINE;
ISOSORBIDE DINITRATE;
ISOSORBIDE HYDRALAZINE COMBINATION;
ISOSORBIDE-HYDRALAZINE COMBINATION;
QUINAZOLINE DERIVATIVE;
ANGINA PECTORIS;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG RESEARCH;
DRUG RESPONSE;
DRUG TARGETING;
HUMAN;
HYPERTENSION;
LUNG TUMOR;
NOTE;
PHARMACOGENETICS;
PRIORITY JOURNAL;
RACE;
AFRICAN AMERICAN;
ARTICLE;
ASIAN;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CONGESTIVE HEART FAILURE;
DRUG COMBINATION;
DRUG INDUSTRY;
ETHNOLOGY;
FOOD AND DRUG ADMINISTRATION;
GENETICS;
GENETICS AND REPRODUCTION;
HEALTH CARE AND PUBLIC HEALTH;
METHODOLOGY;
UNITED STATES;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
GENETICS AND REPRODUCTION;
HEALTH CARE AND PUBLIC HEALTH;
AFRICAN AMERICANS;
ASIAN CONTINENTAL ANCESTRY GROUP;
DRUG COMBINATIONS;
DRUG INDUSTRY;
HEART FAILURE, CONGESTIVE;
HUMANS;
HYDRALAZINE;
ISOSORBIDE DINITRATE;
PHARMACOGENETICS;
QUINAZOLINES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 21344441272
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/4351008a Document Type: Note |
|
Times cited : (11)
|
|
References (0)
|